Curevac Nv Stock Cash Per Share
| 5CV Stock | EUR 2.49 0.09 3.75% |
CureVac NV fundamentals help investors to digest information that contributes to CureVac NV's financial success or failures. It also enables traders to predict the movement of CureVac Stock. The fundamental analysis module provides a way to measure CureVac NV's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CureVac NV stock.
CureVac |
CureVac NV Company Cash Per Share Analysis
CureVac NV's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current CureVac NV Cash Per Share | 7.34 X |
Most of CureVac NV's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CureVac NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, CureVac NV has a Cash Per Share of 7.34 times. This is 68.74% higher than that of the Healthcare sector and 69.52% higher than that of the Biotechnology industry. The cash per share for all Germany stocks is 46.51% lower than that of the firm.
CureVac Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CureVac NV's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CureVac NV could also be used in its relative valuation, which is a method of valuing CureVac NV by comparing valuation metrics of similar companies.CureVac NV is currently under evaluation in cash per share category among its peers.
CureVac Fundamentals
| Return On Equity | -0.19 | |||
| Return On Asset | -0.34 | |||
| Profit Margin | (1.26) % | |||
| Operating Margin | (7.27) % | |||
| Current Valuation | 792.23 M | |||
| Shares Outstanding | 221.98 M | |||
| Shares Owned By Insiders | 45.68 % | |||
| Shares Owned By Institutions | 19.07 % | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 13.59 X | |||
| Revenue | 102.99 M | |||
| Gross Profit | (135.09 M) | |||
| EBITDA | (386.49 M) | |||
| Net Income | (411.72 M) | |||
| Cash And Equivalents | 1.33 B | |||
| Cash Per Share | 7.34 X | |||
| Total Debt | 55.28 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 5.61 X | |||
| Book Value Per Share | 3.29 X | |||
| Cash Flow From Operations | (733.13 M) | |||
| Earnings Per Share | (0.63) X | |||
| Target Price | 72.97 | |||
| Number Of Employees | 764 | |||
| Beta | 2.93 | |||
| Market Capitalization | 1.85 B | |||
| Total Asset | 1.16 B | |||
| Z Score | 19.8 | |||
| Net Asset | 1.16 B |
About CureVac NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CureVac NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CureVac NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CureVac NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in CureVac Stock
When determining whether CureVac NV offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CureVac NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Curevac Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Curevac Nv Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CureVac NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in CureVac Stock please use our How to Invest in CureVac NV guide.You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.